SIREN : 833618556
G.MED is a French company founded 8 years ago, specialized in the sector Autres intermédiaires du commerce en produits divers. Based in ROMANECHE-THORINS (71570), this company of category PME shows in 2022 a revenue of 84 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2022 |
|---|---|
| Revenue | 83 572 € |
| Net income | 245 € |
| EBITDA | 294 € |
| Net margin | 0.3% |
In 2022, G.MED achieves revenue of 84 k€. After deducting consumption (0 €), gross margin stands at 84 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 294 €, representing 0.4% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 245 €, i.e. 0.3% of revenue. This profit can be retained or distributed to shareholders.
83 572 €
83 572 €
294 €
288 €
245 €
0.4%
The debt ratio (= Financial debt / Equity x 100) stands at 113%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 11%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 14.7 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 0.3% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
112.93%
11.397%
0.293%
14.722
In 2022, the debt ratio of G.MED (112.93) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2022, the financial autonomy of G.MED (11.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2022, the repayment capacity of G.MED (14.72) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 132.04. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
132.044
0.0
In 2022, the liquidity ratio of G.MED (132.04) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2022, the interest coverage of G.MED (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 78 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 22 days. The gap of 56 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 17 days of revenue, i.e. 4 k€ to permanently finance.
4 026 €
78 j
22 j
0 j
17 j
Based on 85 transactions of similar company sales
(all years),
the value of G.MED is estimated at
8 311 €
(range 4 622€ - 20 233€).
With an EBITDA of 294€, the sector multiple of 1.0x is applied.
The price/revenue ratio is 0.32x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 85 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare G.MED with other companies in the same sector:
Voir toutes les statistiques du secteur Autres intermédiaires du commerce en produits divers
The revenue of G.MED in 2022 is 84 k€.
Yes, G.MED generated a net profit of 245€ in 2022.
The headquarters of G.MED is located in ROMANECHE-THORINS (71570), in the department Saone-et-Loire.
The tax return of G.MED is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
G.MED operates in the sector Autres intermédiaires du commerce en produits divers (NAF code 46.19B). See the 'Sector positioning' section above to compare the company with its competitors.